An In Vitro Comparison of Anti-Tumoral Potential of Wharton’s Jelly and Bone Marrow Mesenchymal Stem Cells Exhibited by Cell Cycle Arrest in Glioma Cells (U87MG)
Nazneen Aslam(University of Jordan), Abdalla Awidi(University of Jordan), Razan J. Masad(United Arab Emirates University), Walhan Alshaer(Al-Ahliyya Amman University), Dana Alhattab(King Abdullah University of Science and Technology), Hanan Jafar(University of Jordan), Elham Abusharieh(University of Jordan), Duaa Abuarqoub(University of Jordan)
Cited by 16
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123